Chromocell Therapeutics Corp (CHRO)
1.29
-0.03
(-2.27%)
USD |
NYAM |
Jun 12, 16:00
1.35
+0.06
(+4.65%)
After-Hours: 20:00
Chromocell Therapeutics EPS Diluted (Quarterly): -0.2546 for Sept. 30, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -0.2546 |
June 30, 2023 | -0.1707 |
March 31, 2023 | -0.10 |
December 31, 2022 | -0.1354 |
Date | Value |
---|---|
September 30, 2022 | -0.0599 |
June 30, 2022 | -0.036 |
March 31, 2022 | -0.03 |
December 31, 2021 | -0.0226 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.2546
Minimum
Sep 2023
-0.0226
Maximum
Dec 2021
-0.1012
Average
-0.08
Median
EPS Diluted (Quarterly) Benchmarks
iBio Inc | -0.85 |
Lixte Biotechnology Holdings Inc | -0.43 |
PDS Biotechnology Corp | -0.30 |
Syros Pharmaceuticals Inc | -0.10 |
Nutriband Inc | -0.21 |
EPS Diluted (Quarterly) Related Metrics
Net Income (Quarterly) | -1.422M |
Total Expenses (Quarterly) | 1.292M |
Enterprise Value | 8.616M |
Earnings Yield | -51.22% |